Back to search
FDAFDA · Food and drugs·Recall number Z-1396-2024

OptiCross Coronary Imaging Catheter, REF H749518080120

Published April 3, 2024 · Recall initiated: March 5, 2024

Summary

FDA records medical device Class II recall Z-1396-2024, published April 3, 2024 and initiated March 5, 2024. Recalling firm: Boston Scientific Corporation; Status: Ongoing; Reported quantity: 239 units; Lot: UDI/DI 08714729938415, Lot Numbers: 32426901, 32429407, 32625286. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Certain batches of Opticross 40MHz Coronary Imaging Catheters manufactured using an incorrect voltage setting, which may have resulted in decreased image brightness.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Boston Scientific Corporation
Distributor
International distribution to the country of Japan.
Lot
UDI/DI 08714729938415, Lot Numbers: 32426901, 32429407, 32625286
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was OptiCross Coronary Imaging Catheter, REF H749518080120 recalled?

Yes. FDA published recall Z-1396-2024 on April 3, 2024. Reported hazard: Certain batches of Opticross 40MHz Coronary Imaging Catheters manufactured using an incorrect voltage setting, which may have resulted in decreased image brightness.

What should I do if I have this product?

Voluntary: Firm initiated · Letter